A new type of sensor may soon change how doctors understand what’s happening inside the human body. Scientists at Stanford University have created a biosensor that works continuously in live blood ...

It doesn’t just affect the lungs. The airborne pollutants in smoke have been linked to increased risk of stroke, dementia and ...

Favre revealed his diagnosis with Parkinson's disease. Now, he's working to find treatment solutions. Favre joined Ambio Life ...

Roche and Prothena are advancing Prasinezumab to Phase 3 for Parkinson’s despite mixed Phase 2 results. Click here to read an ...

Jefferies analysts said on Tuesday that Ventyx could leverage its mid-stage data for VTX3232 to position the oral drug candidate as a treatment for other neurodegenerative diseases, including ...

A new study reveals that transplanting healthy human glial progenitor cells into adult mice with Huntington’s disease can delay motor and cognitive decline and extend lifespan.

Ventyx Biosciences has shared phase 2a data on a Parkinson’s disease prospect that has caught the eye of Sanofi. The readout shows the effect of VTX3232 on biomarkers, providing some of the data that ...

(GERD) is a prevalent gastrointestinal disorder, with up to 20% of patients developing complications like Erosive ...

Ventyx Biosciences (NASDAQ:VTYX) stock was unchanged following the announcement of top-line data from its Phase 2a safety and biomarker trial evaluating VTX3232 in patients with early-stage ...

Roche has announced that it will be advancing its Prothena-partnered investigational Parkinson’s disease (PD) drug ...

Repeated TBIs are linked to an increased risk of neurodegenerative diseases like early-onset dementia, which has the highest ...